| 000 | 01479 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516125637.0 | ||
| 264 | 0 | _c20130226 | |
| 008 | 201302s 0 0 eng d | ||
| 022 | _a1532-6535 | ||
| 024 | 7 |
_a10.1038/clpt.2012.210 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStocker, S L | |
| 245 | 0 | 0 |
_aThe effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cFeb 2013 |
||
| 300 |
_a186-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacokinetics |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetformin _xpharmacokinetics |
| 650 | 0 | 4 |
_aOrganic Cation Transport Proteins _xgenetics |
| 700 | 1 | _aMorrissey, K M | |
| 700 | 1 | _aYee, S W | |
| 700 | 1 | _aCastro, R A | |
| 700 | 1 | _aXu, L | |
| 700 | 1 | _aDahlin, A | |
| 700 | 1 | _aRamirez, A H | |
| 700 | 1 | _aRoden, D M | |
| 700 | 1 | _aWilke, R A | |
| 700 | 1 | _aMcCarty, C A | |
| 700 | 1 | _aDavis, R L | |
| 700 | 1 | _aBrett, C M | |
| 700 | 1 | _aGiacomini, K M | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 93 _gno. 2 _gp. 186-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/clpt.2012.210 _zAvailable from publisher's website |
| 999 |
_c22372517 _d22372517 |
||